Table 1

Outcome assessment

Category	Outcome	Outcome measure	Baseline (T₀)	6 weeks (T₁)	3 months (T₂)	6 months (T₃)
Primary clinical outcomes	CMDs	SSQ-14	√	√	√	√
Secondary clinical outcomes	Depression	PHQ-9	√	√	√	√
	Anxiety	GAD-7	√	√	√	√
	Social support	MSPSS	√	√	√	√
	Functioning	WHODAS	√	√	√	√
	HRQoL	EQ-5D-5L	√	√	√	√
	Hope	Herth Hope Index	√	√	√	√
	Resilience	Davison Connor Resilience Scale	√	√	√	√
Implementation outcomes	Feasibility	Number of scheduled sessions	√	√	√	√
		Number of sessions completed		√	√	√
	Uptake	Number of clients joining CKT groups		√	√	√
		Number of CKT sessions/activities completed		√	√	√
	Impact and sustainability	Ad hoc costing questionnaire	√	√	√	√
Exploratory–implementation	Satisfaction with services/acceptability	Ad hoc questionnaire		√	√	√
Exploratory–clinical	Therapeutic alliance	Working Alliance Inventory-Short Revised	√	√	√	√

CKT, Circle Kubatana Tose; CMDs, common mental disorders; EQ-5D-5L, EuroQol 5 Dimensions 5 Level; GAD-7, Generalised Anxiety Disorder Assessment; HRQoL, health-related quality of life; MSPSS, Multidimensional Scale of Perceived Social Support; PHQ-9, Patient Health Questionnaire; SSQ-14, Shona Symptom Questionnaire; WHODAS, WHO Disability Assessment Schedule.